Friday, October 02, 2015 4:14:44 PM
I would be excited to see a continuance of this effort!
I think licensing presents many questions because UCSB and others have property rights to our property, and Dept of Energy funded them...
From my perspective that dichotomy may result in HYSR being unwilling to "sell out" or license exclusively to just one particular corporate entity.
We should do some research to determine who SolarCity licensed/obtained their tech from on their new 22% efficiency panel!
Remember we are not in the business of panels... We are in the business of submersible Photoelectrochemically Active Heterostructures
Our main goal is strictly to invent tech to produce the Maximum amount of Hydrogen possible - Knowing that other valuable chemicals will also be produced in the process!
The Electrolyzer unit of a typical Power-To-Gas plant doesn't work with waste water, salt water, and industrial byproducts. We suck the Hydrogen right out of whatever source feedstock there is, whereas an electrolyzer would slowly clog up.
Great research coming out of our scientific teams and further publications to come =)
Lets HOPE that OCTOBER is the end of CHEAP SHARES:
No more shares under 3 cents!
That means No more flipping for small gains here folks!
Recent HYSR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:13:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM